HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
AuthorsBartlett, J. M. S.
Ellis, I. O.
Pinder, S. E.
Walker, R. A.
MetadataShow full item record
CitationHER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods 2011, 64 (8):649 Journal of Clinical Pathology
JournalJournal of Clinical Pathology
AbstractThese guidelines supplement existing guidelines on HER2 testing by immunohistochemistry and in-situ hybridisation(ISH) methods in the UK. They provide a specific focus on aspects of guidance relevant to HER2 ISH testing methods, both fluorescent and chromogenic. They are formulated to give advice on methodology, interpretation and quality control for ISH-based testing of HER2 status in common tumour types, including both breast and gastric tumours. The aim is to ensure that all ISH-based testing is accurate, reliable and timely.